Phase 4Completed

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus. (ADHERE)

A Multicenter, Two Arm, Randomized, Open Label Clinical Study Investigating Renal Function in an Advagraf® Based Immunosuppressive Regimen With or Without Sirolimus in Kidney Transplant Patients

Sponsor
Astellas Pharma Inc (Industry)
Enrollment
853 enrolled
Conditions
Kidney Transplantation
Interventions
Advagraf; Mycophenolate Mofetil; Sirolimus; Corticosteroids
Ages
adults, older adults
Registry
NCT01363752, EUCTR2010-019639-37

Full record on ClinicalTrials.gov

From the registry

The purpose of this study is to compare the effect of two anti-rejection therapy regimens on kidney function in kidney transplant recipients.

Primary outcomes

  • Glomerular Filtration Rate (GFR) estimated by iohexol clearance at Week 52 post kidney transplantation

History

  1. Last registry update

  2. Primary completion

  3. Registered

  4. Started